Understanding and exploiting novel therapeutic vulnerabilities of RIT1-driven lung cancer

$778.5K USD

Funder	NATIONAL CANCER INSTITUTE
Recipient Organization	Fred Hutchinson Cancer Center
Country	United States
Start Date	Apr 01, 2021
End Date	Mar 31, 2026
Duration	1,825 days
Number of Grantees	1
Roles	Principal Investigator
Data Source	NIH (US)
Grant ID	`10746645`

Grant Description

PROJECT SUMMARY/ABSTRACT Per the FOA, this section is not required. The research supplement proposal does not change the activities of the parent award.